Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Rheumatoid arthritis Primer — behind the scenes

Nature Reviews Disease Primers volume 6, Article number: 32 (2020) Cite this article

Subjects

Comprehensive review articles written by international experts are important to provide readers from diverse backgrounds with an expanding knowledge base.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Smolen, J. S. et al. Rheumatoid arthritis. Nat. Rev. Dis. Primers 4, 18001 (2018).

    Article  Google Scholar 

  2. Smolen, J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann. Rheum. Dis. https://doi.org/10.1136/annrheumdis-2019-216655 (2020).

    Article  PubMed  Google Scholar 

  3. Lund Hetland, M. et al. A multicenter randomized study in early rheumatoid arthritis to compare active conventional therapy versus three biological treatments: 24 week efficacy and safety results of the NORD-STAR Trial [abstract L09]. Arthritis Rheumatol. 71 (Suppl. 10), 5237–5240 (2019).

    Google Scholar 

  4. Croft, A. P. et al. Distinct fibroblast subsets drive inflammation and damage in arthritis. Nature 570, 246–251 (2019).

    Article  CAS  Google Scholar 

  5. Aletaha, D. & Smolen, J. S. Remission in rheumatoid arthritis: missing objectives by using inadequate DAS28 targets. Nat. Rev. Rheumatol. 15, 633–634 (2019).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, Medical University of Vienna, Vienna, Austria

    Josef S. Smolen

Authors
  1. Josef S. Smolen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Josef S. Smolen.

Ethics declarations

Competing interests

J.S. receives research grants from Abbvie, AstraZeneca, Lilly, Merck Sharpe & Dohme, Pfizer and Roche; and honoraria for expert advice for or symposia speaking engagements with AbbVie, Amgen, AstraZeneca, Astro, Bristol-Myers Squibb, Celgene, Celltrion, Chugai, Gilead, ILTOO Pharma, Janssen, Lilly, Merck Sharp & Dohme, Novartis-Sandoz, Pfizer, Roche, Samsung, Sanofi and UCB.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Smolen, J.S. Rheumatoid arthritis Primer — behind the scenes. Nat Rev Dis Primers 6, 32 (2020). https://doi.org/10.1038/s41572-020-0168-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41572-020-0168-y

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing